Sino Biopharmaceutical Ltd
HKEX:1177
Dividends
Dividend Yield
Sino Biopharmaceutical Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Sino Biopharmaceutical Ltd
Sino Biopharmaceutical Ltd have
increased
by 275%.
Payout Ratio
Sino Biopharmaceutical Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for Sino Biopharmaceutical Ltd is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Sino Biopharmaceutical Ltd
| Average Annual Return | -21.44% |
| Standard Deviation of Annual Returns | 12.1% |
| Max Drawdown | -73% |
| Market Capitalization | 107.7B HKD |
| Shares Outstanding | 18 760 720 000 |
| Percentage of Shares Shorted |
N/A
|
Return Decomposition
Main factors of price return
Stock Splits
Sino Biopharmaceutical Ltd's latest stock split occurred on Jul 20, 2020
The company executed a 479156-for-319437 stock split, meaning that for every 319437 shares held, investors received 479156 new shares.
Before the split, Sino Biopharmaceutical Ltd traded at 22.71 per share. Afterward, the share price was about 9.7078.
The adjusted shares began trading on Jul 20, 2020. This was Sino Biopharmaceutical Ltd's 7th stock split, following the previous one in Jun 4, 2018.
